对侧颈动脉闭塞与CEA后围手术期卒中风险增加相关而与CAS无关:43项研究96,658例患者的荟萃分析与Meta回归
该系统评价纳入43项研究(46个研究臂)共96,658例患者(CEA 75,857例,CAS 20,801例),其中对侧颈动脉闭塞(CCO)组9,258例,比较有无CCO患者颈动脉血运重建的围手术期结局。结果显示CCO患者30天死亡、卒中、TIA及卒中/死亡复合终点风险均升高,亚组分析中CEA合并CCO者卒中、死亡、TIA及卒中/死亡风险增加,而CAS合并CCO者仅死亡风险增加,卒中与TIA风险未见增加。
要点
- CCO患者颈动脉血运重建后30天卒中、死亡、TIA及卒中/死亡复合终点风险均显著升高
- CEA合并CCO者围手术期卒中风险增加(OR 2.07),而CAS合并CCO者卒中风险未见增加
- CCO患者围手术期心肌梗死风险未见差异
核心结论
- 颈动脉血运重建结局受CCO存在的不利影响,CCO患者围手术期卒中、死亡和TIA风险显著更高。
- CEA合并CCO与围手术期卒中、死亡、TIA及死亡/卒中风险增加相关。
- CAS合并CCO与围手术期死亡风险增加相关,但卒中或TIA风险未增加。
研究设计与样本
- 检索PubMed、Scopus和Cochrane数据库至2018年9月,纳入比较有无CCO患者颈动脉血运重建结局的观察性或随机研究。
- 共纳入43项研究(46个研究臂)96,658例患者,其中CEA 75,857例、CAS 20,801例,CCO组9,258例。
- 异质性采用Higgins I2检验评估,I2>75%提示显著异质性,采用随机效应模型合并,结果以OR及95%CI报告。
- 采用Meta回归分析考察潜在混杂因素,发表偏倚用Egger法定量评估。
主要发现
- CCO患者颈动脉血运重建与30天死亡风险增加相关(OR 1.75,95%CI 1.38~2.23,p<0.001;I2=0%)。
- CCO患者卒中风险增加(OR 1.77,95%CI 1.41~2.22,p<0.001;I2=46%),TIA风险增加(OR 2.10,95%CI 1.34~3.27,p=0.001;I2=15%)。
- CCO患者卒中/死亡复合终点风险增加(OR 1.78,95%CI 1.54~2.05,p<0.001;I2=0%),围手术期心肌梗死风险未见差异(OR 0.81,95%CI 0.50~1.31,p=0.388;I2=0%)。
- CEA合并CCO者卒中(OR 2.07,95%CI 1.72~2.49,p<0.001;I2=14%)、死亡(OR 1.80,95%CI 1.55~2.10,p<0.001;I2=0%)、TIA(OR 2.18,95%CI 1.38~3.45,p<0.001;I2=13%)及卒中/死亡(OR 1.80,95%CI 1.55~2.10,p<0.001;I2=0%)风险均增加。
- CAS合并CCO者死亡风险增加(OR 1.65,95%CI 1.07~2.60,p=0.023;I2=0%),但卒中(OR 0.94,95%CI 0.61~1.47;p=0.080;I2=31%)和TIA(OR 1.18,95%CI 0.18~7.55;p=0.861;I2=43%)风险未增加。
关键数值与推荐
- Meta回归分析未发现任何结局的显著关联,且无发表偏倚证据。
- CCO组共9,258例,CEA 75,857例、CAS 20,801例,总样本96,658例。
- 异质性判定阈值为I2>75%提示显著异质性。
临床怎么用
- 对合并对侧颈动脉闭塞的患者行颈动脉血运重建前应充分评估围手术期卒中、死亡和TIA风险。
- CEA合并CCO者围手术期卒中风险显著增加,选择术式时需权衡;CAS合并CCO者卒中风险未见增加但死亡风险升高。
- CCO患者围手术期心肌梗死风险未见明显增加,围手术期管理重点应侧重于神经系统并发症与死亡风险。
局限性
- Meta回归分析未发现任何结局的显著关联,无法明确校正后的独立危险因素。
- 亚组分析中CAS合并CCO的TIA结果置信区间宽(95%CI 0.18~7.55),提示该亚组样本量有限、估计不精确。
- 部分结局存在轻中度异质性(如卒中I2=46%、CAS卒中I2=31%、CAS TIA I2=43%),合并结果需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Purpose: To investigate the prognostic role of contralateral carotid artery occlusion (CCO) in perioperative outcomes of patients undergoing carotid artery endarterectomy (CEA) vs carotid artery stenting (CAS). Materials and Methods: The PubMed, Scopus, and Cochrane databases were searched up to September 2018 to identify observational or randomized studies that compared outcomes of carotid revascularization in patients with vs without CCO. Forty-three studies (46 arms) comprising 96,658 patients were selected (75,857 CEA and 20,801 CAS). The CCO group included 9258 patients. Heterogeneity was assessed with the Higgins I2 test. I2>75% indicated significant heterogeneity. A random effects model was used to account for heterogeneity among studies. The results were reported as the odds ratios (ORs) with the 95% confidence intervals (CIs). Meta-regression analysis examined potential confounders. Publication bias was quantified by the Egger method. Results: Carotid revascularization in patients with CCO was associated with an increased risk of 30-day mortality (OR 1.75, 95% CI 1.38 to 2.23, p<0.001; I2=0%), stroke (OR 1.77, 95% CI 1.41 to 2.22, p<0.001; I2=46%), transient ischemic attack (TIA) (OR 2.10, 95% CI 1.34 to 3.27, p=0.001; I2=15%), and the composite endpoint of stroke/death (OR 1.78, 95% CI 1.54 to 2.05, p<0.001; I2=0%). No difference was noted in the risk of perioperative myocardial infarction (OR 0.81, 95% CI 0.50 to 1.31; p=0.388; I2=0%). Subgroup analysis demonstrated that CEA in patients with CCO was associated with an increased risk of stroke (OR 2.07, 95% CI 1.72 to 2.49, p<0.001; I2=14%), death (OR 1.80, 95% CI 1.55 to 2.10, p<0.001; I2=0%), TIA (OR 2.18, 95% CI 1.38 to 3.45, p<0.001; I2=13%), and stroke/death (OR 1.80, 95% CI 1.55 to 2.10, p<0.001; I2=0%), whereas CCO patients who were treated with CAS were at an increased risk for death (OR 1.65, 95% CI 1.07 to 2.60, p=0.023; I2=0%) but not stroke (OR 0.94, 95% CI 0.61 to 1.47; p=0.080; I2=31%) or TIA (OR 1.18, 95% CI 0.18 to 7.55; p=0.861; I2=43%). The meta-regression analysis did not find any significant association for any of the outcomes, and there was no evidence of publication bias. Conclusion: Carotid revascularization outcomes are adversely affected by the presence of CCO. Patients with CCO have a significantly higher risk of periprocedural stroke, death, and TIA. CEA in patients with CCO is associated with an increased risk of perioperative stroke, death, TIA, and death/stroke, while CAS in the presence of a CCO is associated with an increased risk of periprocedural death but not stroke or TIA.
引用
- Kokkinidis DG, Chaitidis N, Giannopoulos S, et al. Presence of Contralateral Carotid Occlusion Is Associated With Increased Periprocedural Stroke Risk Following CEA but Not CAS: A Meta-analysis and Meta-regression Analysis of 43 Studies and 96,658 Patients. J Endovasc Ther. 2020. PMID: 32066317. doi:10.1177/1526602820904163
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。